Showing results (831-840 of 1,014) with videos related to
Sort By:
Pageof 102
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Electrophysiology of the corticomotoneurone pathways in patients with movement disordersP D Thompson, J P Dick, B L Day, et al.Neurology|September 1, 1993
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's diseaseM Vidailhet, F Stocchi, J C Rothwell, et al.Nature|August 2, 1984
The corticomotoneurone connection is normal in Parkinson's diseaseJ P Dick, J M Cowan, B L Day, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Administration of MPTP to the common marmoset does not alter cortical cholinergic functionJ Garvey, M Petersen, C M Waters, et al.Biochemical Pharmacology|October 17, 1998
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's diseaseK S McNaught, P A Carrupt, C Altomare, et al.Neurology|December 31, 1997
Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degenerationO Bandmann, M G Sweeney, S E Daniel, et al.Neurology|October 22, 1998
A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study GroupA Lieberman, C W Olanow, K Sethi, et al.British Journal of Urology|October 1, 1989
The value of urethral sphincter electromyography in the differential diagnosis of parkinsonismI Eardley, N P Quinn, C J Fowler, et al.Nature|January 2, 1986
1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathwayA J Bradbury, B Costall, A M Domeney, et al.Brain : a Journal of Neurology|April 1, 1988
The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movementP D Thompson, A Berardelli, J C Rothwell, et al.Pageof 102